Membership and Registrations
◆About applications for sponsorship (groups) and individual membership◆
As a "community lab," YORIAILab will work with our clinical trial ambassadors to foster "fruitful" patient and public participation in drug development, and support and practice social co-creation to deliver valuable treatments to those who need them more quickly.
Why not become a member of YORIAILab and join us in "social co-creation"?
Furthermore, in order to realize various co-creation activities and conduct more fulfilling business operations, we ask for sponsorship from companies and organizations that understand and agree with our aims.
◆About applying to participate in clinical trial ambassador training◆
Starting in 2025, courses will be offered twice a year
We are now accepting applications for Clinical Trial Ambassador V (5th term , starting August 2025)
Clinical Trial Ambassador Participation Requirements
subject:
Patients and their families (regardless of whether they belong to a patient organization), patient support organizations, and the general public
*In the future, we plan to make arrangements so that medical institutions and companies can also participate.
Age: No restrictions (those under 18 need parental consent)
Those who want to actively learn about pharmaceutical development (clinical trials)
* Clinical Trial Ambassador Training is free to attend. Some sessions will be held in a hybrid format, both online and on-site, but if you wish to participate on-site, we will consider travel arrangements.
In principle, participants are responsible for their own accommodation costs .
*If there are a large number of applicants, we may ask you to participate in the next Clinical Trial Ambassador Training.
Clinical Trial Ambassador Training Schedule (5th Period)
*Current schedule. Generally Mondays or Wednesdays (you can choose either one, with some exceptions for Fridays)
The event will be held from 19:00 to 21:00 on the 24th of each month. The date may change depending on the circumstances.
Please understand this.
